ArticleJournal of the National Cancer Institute2021

Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040.

Kevin J Harrington et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.